Imbio PHA (4.0.0) vs IM007
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A specializes in AI-powered analysis of CT pulmonary angiogram scans to measure cardiac structures, aiding in the diagnosis and risk stratification of pulmonary embolism and hypertension. In contrast, Tool B is an AI-powered platform for remote cardiac monitoring, aggregating data from cardiac implantable electronic devices to streamline workflows and manage alerts. While both leverage AI in cardiology, they address distinct clinical needs: diagnostic imaging analysis versus remote device management.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
Imbio PHA (4.0.0) is designed to assess potential right ventricular dilation from CT pulmonary angiogram (CTPA) scans, aiding in the diagnosis and risk stratification of pulmonary embolism and hypertension. IM007, on the other hand, is an AI-powered, cloud-based platform for remote cardiac monitoring, aggregating data from cardiac implantable electronic devices (CIEDs) to streamline workflows and improve patient outcomes in cardiology and heart failure management.
Imbio PHA (4.0.0) analyzes medical images, specifically CT pulmonary angiogram (CTPA) scans, to measure cardiac structures. IM007 aggregates and analyzes data from various cardiac implantable electronic devices (CIEDs) such as those from Abbott, Biotronik, Boston Scientific, Medtronic, and MicroPort.
Imbio PHA (4.0.0) utilizes AI algorithms for automated anatomical identification and measurement of cardiac structures from CTPA scans, providing objective data for diagnosis and risk stratification. IM007 employs AI for advanced alert management, significantly reducing false positives from CIEDs (e.g., 79% for ILR ECG Analyzer, 85% for AF alerts), and includes SignalHF, an FDA-cleared predictive AI for heart failure hospitalization risk.
Imbio PHA (4.0.0) is primarily intended for use in Cardiology, Pulmonology, and Radiology. IM007 is designed for Cardiology and Hospital Medicine, focusing on remote monitoring and management of patients with cardiac implantable electronic devices.
Imbio PHA (4.0.0) generates automated measurements of right and left ventricle diameters, main pulmonary artery and aorta diameters, RV/LV and PA/Ao ratios, annotated DICOM images, and summary reports in PDF format. IM007 provides unified device data aggregation, AI-driven alert management, smart workflow automation for billing and reporting, and predictive insights like the ILR ECG Analyzer and SignalHF for heart failure risk.